On the basis of big data analysis, we used PCR and Western blot experiments to verify that the expression level of ARRDC2 in normal ovarian cells (IOSE80) was significantly lower than that in ovarian cancer cells (A2780 and SKOV3) (Figures 8A,B). Here, ARRDC2 is linked to ovarian carcinoma.